Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 5,959 shares at $74.00 ($439K) on 2022-08-03, disclosed to the SEC on 2022-08-04.
Seasonal sale ($439k) by Chief Medical Officer — this insider has traded NVCR in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.09 | 563 | $40K | 9.1% |
| 2 | $74.00 | 5,396 | $399K | 90.9% |
| Total | $73.73 avg | 5,959 | $439K | 100% |
| Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |
| NVCR | SELL | 2021-08-03 | $367K | — | Filing → |